ID: ALA2181475

Max Phase: Preclinical

Molecular Formula: C16H23ClN2O4

Molecular Weight: 306.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(C)C(=O)Oc1cccc2c1C(CCC(=O)OC)CN2.Cl

Standard InChI:  InChI=1S/C16H22N2O4.ClH/c1-4-18(2)16(20)22-13-7-5-6-12-15(13)11(10-17-12)8-9-14(19)21-3;/h5-7,11,17H,4,8-10H2,1-3H3;1H

Standard InChI Key:  RMEOAJCQENJBFD-UHFFFAOYSA-N

Associated Targets(non-human)

H9c2 3506 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Butyrylcholinesterase 805 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Acetylcholinesterase 1035 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RAW264.7 28094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase p38 226 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Inhibitor of nuclear factor kappa-B kinase subunit alpha 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cholinesterase 8742 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 306.36Molecular Weight (Monoisotopic): 306.1580AlogP: 2.60#Rotatable Bonds: 5
Polar Surface Area: 67.87Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.38CX LogP: 1.64CX LogD: 1.64
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: -0.08

References

1. Yanovsky I, Finkin-Groner E, Zaikin A, Lerman L, Shalom H, Zeeli S, Weill T, Ginsburg I, Nudelman A, Weinstock M..  (2012)  Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease.,  55  (23): [PMID:23151013] [10.1021/jm301411g]
2. Furman S, Nissim-Bardugo E, Zeeli S, Weitman M, Nudelman A, Finkin-Groner E, Moradov D, Shifrin H, Schorer-Apelbaum D, Weinstock M..  (2014)  Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages.,  24  (10): [PMID:24731278] [10.1016/j.bmcl.2014.03.081]

Source